| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.17T | 17.33T | 17.94T | 17.61T | 17.30T | 16.75T |
| Gross Profit | 12.57T | 3.30T | 15.66T | 15.39T | 15.05T | 14.52T |
| EBITDA | 4.58T | 4.60T | 5.86T | 5.63T | 5.32T | 6.11T |
| Net Income | 376.02B | 413.95B | 1.25T | 1.09T | 912.40B | 2.41T |
Balance Sheet | ||||||
| Total Assets | 29.58T | 30.11T | 30.52T | 30.12T | 31.31T | 30.91T |
| Cash, Cash Equivalents and Short-Term Investments | 1.75T | 1.68T | 2.35T | 1.75T | 2.12T | 1.39T |
| Total Debt | 10.46T | 10.77T | 10.76T | 10.66T | 11.08T | 10.37T |
| Total Liabilities | 16.82T | 17.55T | 18.69T | 17.89T | 19.15T | 18.58T |
| Stockholders Equity | 12.70T | 12.46T | 11.70T | 11.39T | 11.32T | 11.58T |
Cash Flow | ||||||
| Free Cash Flow | 1.69T | 1.72T | 2.53T | 1.87T | 2.11T | 1.72T |
| Operating Cash Flow | 3.73T | 3.96T | 5.09T | 4.95T | 5.16T | 5.03T |
| Investing Cash Flow | -1.75T | -1.76T | -2.71T | -3.35T | -2.81T | -3.49T |
| Financing Cash Flow | -2.79T | -2.73T | -1.81T | -2.02T | -1.35T | -2.05T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $21.44B | 16.96 | 9.28% | 5.03% | 10.34% | 17.26% | |
66 Neutral | $8.30B | 9.51 | 8.77% | 4.13% | 13.45% | 148.36% | |
65 Neutral | $13.56B | 57.39 | 3.00% | 5.02% | -7.08% | -73.85% | |
64 Neutral | $17.18B | 17.16 | 12.76% | 6.14% | -6.44% | -27.87% | |
62 Neutral | $34.52B | -72.60 | -0.79% | 3.77% | 16.69% | 87.12% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |